EP1572987A4 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
EP1572987A4
EP1572987A4 EP20010907128 EP01907128A EP1572987A4 EP 1572987 A4 EP1572987 A4 EP 1572987A4 EP 20010907128 EP20010907128 EP 20010907128 EP 01907128 A EP01907128 A EP 01907128A EP 1572987 A4 EP1572987 A4 EP 1572987A4
Authority
EP
Grant status
Application
Patent type
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20010907128
Other languages
German (de)
French (fr)
Other versions
EP1572987A2 (en )
Inventor
Y Tom Tang
Chenghua Liu
Radoje T Drmanac
Vinod Asundi
Ping Zhou
Chongjun Xu
Yicheng Cao
Yunquing Ma
Qing A Zhao
Dunrui Wang
Jian-Rui Wang
Jie Zhang
Feiyan Ren
Rui-Hong Chen
Zhi Wei Wang
Aidong J Xue
Yonghong Yang
Tom Wejhrman
Ryle Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6432Coagulation factor Xa (3.4.21.6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21006Coagulation factor Xa (3.4.21.6)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
EP20010907128 2000-02-03 2001-02-05 Novel nucleic acids and polypeptides Withdrawn EP1572987A4 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
US728422 1991-07-11
US49691400 true 2000-02-03 2000-02-03
US496914 2000-02-03
US56087500 true 2000-04-27 2000-04-27
US560875 2000-04-27
US59807500 true 2000-06-20 2000-06-20
US598075 2000-06-20
US62032500 true 2000-07-19 2000-07-19
US620325 2000-07-19
US65493600 true 2000-09-01 2000-09-01
US654936 2000-09-01
US66356100 true 2000-09-15 2000-09-15
US663561 2000-09-15
US69332500 true 2000-10-20 2000-10-20
US693325 2000-10-20
US09728422 US20020128187A1 (en) 2000-02-03 2000-11-30 Novel nucleic acids and polypeptides
PCT/US2001/004098 WO2001057190A3 (en) 2000-02-03 2001-02-05 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1572987A2 true EP1572987A2 (en) 2005-09-14
EP1572987A4 true true EP1572987A4 (en) 2005-11-30

Family

ID=27575454

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20010907128 Withdrawn EP1572987A4 (en) 2000-02-03 2001-02-05 Novel nucleic acids and polypeptides

Country Status (3)

Country Link
EP (1) EP1572987A4 (en)
CA (1) CA2399776A1 (en)
WO (1) WO2001057190A3 (en)

Families Citing this family (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030077594A1 (en) 1997-06-16 2003-04-24 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030003507A1 (en) 1999-06-02 2003-01-02 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US6329503B1 (en) 1998-06-01 2001-12-11 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
EP1210418B1 (en) * 1999-06-02 2010-08-18 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
JP2002534112A (en) 1999-01-15 2002-10-15 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド Bone marrow-specific proteins
WO2001068848A3 (en) * 2000-03-01 2002-08-29 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1377409A (en) * 1999-08-19 2002-10-30 黑川清 MEG-1 protein
US20020042062A1 (en) 1999-09-24 2002-04-11 Mark Stearns Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US7754435B2 (en) * 2000-09-21 2010-07-13 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US7790861B2 (en) * 1999-09-24 2010-09-07 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
JP2003520031A (en) * 1999-11-12 2003-07-02 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 28 pieces of human secreted proteins
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
CA2395416A1 (en) 1999-12-23 2001-06-28 Millennium Pharmaceuticals, Inc. P2y12 receptor
CA2399860A1 (en) 2000-02-11 2001-08-16 Glycozym Aps Udp-galactose: .beta.-d-galactose-r 4-.alpha.-d-galactosyltransferase, .alpha.4gal-t1
JP4342069B2 (en) * 2000-02-14 2009-10-14 鋼一 古川 α1,4- galactosyltransferase and DNA encoding it
WO2001070974A1 (en) * 2000-03-24 2001-09-27 Takeda Chemical Industries, Ltd. Novel protein, process for producing the same and use thereof
CA2405104A1 (en) * 2000-04-05 2001-10-18 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
EP1287124A2 (en) * 2000-04-18 2003-03-05 Bayer Aktiengesellschaft Regulation of human epithin-like serine protease
EP1280917A2 (en) * 2000-04-26 2003-02-05 Millennium Pharmaceuticals, Inc. 21657, a human short-chain dehydrogenase and uses thereof
US20030092035A1 (en) 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
US7510845B2 (en) 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
WO2001085935A3 (en) * 2000-05-09 2002-04-11 Bayer Ag Endothelial differentiation gene 6-like g protein coupled receptor
EP1311688A2 (en) * 2000-05-26 2003-05-21 Millennium Pharmaceuticals, Inc. 50250, a human lipase and uses thereof
US20020065223A1 (en) * 2000-06-16 2002-05-30 Glucksmann Maria Alexandra 33358, a novel human ankyrin family member and uses thereof
CA2414015A1 (en) * 2000-06-21 2001-12-27 Incyte Genomics, Inc. Human receptors
US20020172678A1 (en) 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US20020031815A1 (en) * 2000-06-26 2002-03-14 Millennium Pharmaceuticals, Inc. 46619, a novel human beta-ketoacyl synthase and uses thereof
WO2002002599A3 (en) * 2000-06-30 2002-10-10 Ingenium Pharmaceuticals Ag HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
WO2002006312A3 (en) * 2000-07-13 2003-03-20 Novartis Ag Disease-associated gene
WO2002008392A3 (en) * 2000-07-25 2002-11-21 Bayer Ag Regulation of human matriptase-like serine protease
EP1307557A2 (en) 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns
US20020187138A1 (en) * 2000-08-02 2002-12-12 Rachel Meyers 15368, a novel human GTP-releasing factor family member and uses therefor
CA2417368A1 (en) * 2000-08-04 2002-02-14 Xin Lu Suppressor gene
EP1688496A3 (en) * 2000-08-14 2006-08-16 Actimis Pharmaceuticals, Inc., Regulation of human P2Y1-like G protein-coupled receptor
DK1311677T3 (en) * 2000-08-14 2006-05-22 Actimis Pharmaceuticals Inc Regulation of the human P2Y 1-like G protein-coupled receptor
WO2002014483A3 (en) * 2000-08-15 2003-04-24 Zymogenetics Inc Human adenosine deaminase
US6706513B2 (en) 2000-08-21 2004-03-16 Bristol-Myers Squibb Company Adenosine deaminase homolog
WO2002018552A8 (en) * 2000-08-30 2003-05-08 Bayer Ag Regulation of human aminotransferase-like enzyme
US20030166300A1 (en) * 2000-08-30 2003-09-04 Tang Y. Tom Growth-related inflammatory and immune response protein
WO2002022777A3 (en) * 2000-09-15 2002-10-24 Christian Brechot Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
US20030204052A1 (en) * 2000-10-04 2003-10-30 Herrmann John L. Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002031126A3 (en) * 2000-10-11 2002-12-05 Bayer Ag Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
US6984502B2 (en) 2000-10-19 2006-01-10 Millennium Pharmaceuticals, Inc. Methods and compositions of human 69087 nucleic acids and uses thereof
JP2004532609A (en) 2000-11-03 2004-10-28 ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア Proxy phenethyl Shin polypeptides, related compositions and methods
EP1364012A2 (en) * 2000-11-08 2003-11-26 Millennium Pharmaceuticals, Inc. 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
EP1339866B1 (en) * 2000-11-09 2010-09-01 University Of Virginia Patent Foundation Human testis specific serine/threonine kinase
WO2002038743A3 (en) * 2000-11-09 2003-01-09 Glaxo Group Ltd Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
US7312086B2 (en) 2000-12-07 2007-12-25 Bristol-Myers Squibb Company Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
WO2002050279A3 (en) * 2000-12-21 2003-07-03 Incyte Genomics Inc Nucleic acid-associated proteins
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
WO2002053719A3 (en) * 2001-01-04 2003-07-24 Yalda Azimzai Cytoskeleton-associated proteins
CA2433843A1 (en) * 2001-01-05 2002-08-22 Incyte Genomics, Inc. Molecules for disease detection and treatment
US6319679B1 (en) * 2001-01-26 2001-11-20 Board Of Regents, The University Of Texas System PAS kinase
US20020115136A1 (en) * 2001-02-07 2002-08-22 Gennady Merkulov Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002064777A3 (en) * 2001-02-14 2003-12-04 Axaron Bioscience Ag Proteins 7b6 and 11b4 and dna sequences encoding the same
JP2005508606A (en) * 2001-03-16 2005-04-07 インサイト・ゲノミックス・インコーポレイテッド Nucleic acid-related protein
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
US20050202431A1 (en) * 2002-04-01 2005-09-15 National Institute Of Advanced Industrial Science Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
US20020146795A1 (en) * 2001-04-02 2002-10-10 Shiaoping Zhu Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
US7736654B2 (en) 2001-04-10 2010-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) * 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
US6962811B2 (en) 2001-05-09 2005-11-08 Millennium Pharmaceuticals, Inc. 14715, a human fringe family member nucleic acids and uses therefor
CN100463967C (en) 2001-05-29 2009-02-25 人体细胞组织有限公司 Testicular carnitine transfer protein and its gene
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2449289A1 (en) 2001-06-05 2002-12-12 Exelixis, Inc. Gfats as modifiers of the p53 pathway and methods of use
KR100607612B1 (en) * 2001-06-20 2006-08-02 제넨테크, 인크. Compositions and Methods for the Diagnosis and Treatment of Tumor
WO2003000874A3 (en) * 2001-06-25 2003-05-22 Bayer Ag Regulation of human serine/threonine protein kinase nek3
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
US20060073150A1 (en) 2001-09-06 2006-04-06 Mary Faris Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
EP1526382B1 (en) * 2001-09-24 2007-01-03 Grünenthal GmbH Screening method for different indications using DNPI
US7265214B2 (en) * 2001-10-19 2007-09-04 Rigel Pharmaceuticals, Inc. Germinal center kinase proteins, compositions and methods of use
WO2003038040A3 (en) * 2001-10-29 2005-01-13 Millennium Pharm Inc 32235, a human aminotransferase family member and uses therefor
US20030143231A1 (en) * 2001-10-31 2003-07-31 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment and diagnosis of pain disorders using 57749
WO2003037253A3 (en) * 2001-10-31 2003-07-31 Millennium Pharm Inc Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
DE60220621T2 (en) 2001-11-09 2008-03-06 Proteologics, Inc. Posh nucleic acid, polypeptides and related methods
WO2003048326A3 (en) * 2001-12-03 2004-12-02 Nuvelo Inc Methods and materials relating to novel polypeptides and polynucleotides
EP1450852B1 (en) * 2001-12-04 2007-01-17 DeveloGen Aktiengesellschaft Ptp10d nucleic acids and peptides involved in the regulation of energy homeostasis
WO2003054153A3 (en) * 2001-12-12 2003-11-06 Terence L Kirley Apyrase polypeptides and nucleic acids encoding same
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
US7572886B2 (en) 2001-12-18 2009-08-11 Centre National De La Recherche Scientifique Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
US20050176632A1 (en) * 2002-02-04 2005-08-11 Tetsuya Ohtaki Angiogenesis inhibitors
GB0205112D0 (en) * 2002-03-05 2002-04-17 Pantherix Ltd Enzyme
WO2003076072A1 (en) 2002-03-11 2003-09-18 Japan Science And Technology Agency Practical chiral zirconium catalyst
DE10212397A1 (en) * 2002-03-20 2003-10-16 Universitaetsklinikum Freiburg Repressor of skeletal muscle differentiation, nucleic acid encoding it and to its use in diagnosis and therapy
CA2480671A1 (en) * 2002-03-29 2003-10-23 Celestar Lexico-Sciences, Inc. C-jun phosphorylation inhibitors
WO2003091447A3 (en) 2002-04-26 2004-08-26 David J Anderson D1-1 nucleic acids, polypeptides and related methods
US7622443B2 (en) 2002-04-26 2009-11-24 California Institute Of Technology Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides
DE10222845A1 (en) * 2002-05-23 2003-12-04 Dresden Arzneimittel Cloning, expression and characterization of the overall sequence of phosphodiesterase 8B
JP4416650B2 (en) * 2002-06-28 2010-02-17 イムクローン・リミテッド・ライアビリティ・カンパニーImclone LLC The novel polynucleotide and polypeptide sequences and their use
US20060264610A1 (en) * 2002-07-19 2006-11-23 Cellzome Ag Protein complexes of the tip60 transcriptional activator protein
US7135556B2 (en) 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
JP2004290170A (en) * 2002-08-02 2004-10-21 Takeda Chem Ind Ltd Use of gene associated with disease
EP2278028A1 (en) * 2002-09-30 2011-01-26 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
US20080213166A1 (en) * 2002-11-20 2008-09-04 Biogen Idec Inc. Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
WO2004055050A9 (en) * 2002-12-10 2005-12-15 Endocube Sas Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
JP4140951B2 (en) * 2002-12-18 2008-08-27 独立行政法人科学技術振興機構 Transcription factor zhx3
EP2141235B1 (en) 2002-12-29 2014-06-11 Toudai Tlo, Ltd. Adiponectin receptor and gene coding for the same
JP2006518997A (en) * 2003-01-21 2006-08-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company New acyl-coenzyme a: polynucleotides and uses thereof encoding monoacylglycerol acyltransferase -3 (mgat3)
CA2514971C (en) * 2003-02-03 2012-08-14 Japan Science And Technology Agency Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
EP1599498A2 (en) * 2003-03-03 2005-11-30 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
JP2007525183A (en) * 2003-04-30 2007-09-06 アジェンシス, インコーポレイテッド It termed useful 109p1d4 in the treatment and detection of cancer, the nucleic acid and corresponding protein
WO2004104218A1 (en) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase (aminopeptidase p) 1 (xpnpep1)
WO2005023855A3 (en) * 2003-09-10 2005-05-19 Friedrich Alexander Uni Versit K203 gene and protein
US7534562B2 (en) * 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
WO2005059504A3 (en) * 2003-12-12 2005-11-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor gpr34 (gpr34)
WO2005069900B1 (en) 2004-01-16 2006-08-03 Merck & Co Inc Npc1l1 (npc3) and methods of identifying ligands thereof
EP1723227A4 (en) * 2004-02-10 2007-09-19 Dartmouth College Nicotinamide riboside kinase compositions and methods for using the same
EP1786833A4 (en) 2004-03-19 2009-02-25 Univ Yale Detection, isolation and uses of renalase (monoamine oxidase c)
EP2289911A3 (en) * 2004-03-30 2011-03-30 NsGene A/S Therapeutic use of a growth factor, NsG33
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
CA2563735A1 (en) 2004-04-22 2005-12-01 Agensys, Inc. Antibodies and molecules derived therefrom that bind to steap-1 proteins
ES2414460T3 (en) 2004-08-04 2013-07-19 Amgen Inc. Dkk-1 antibodies
WO2006069592A3 (en) * 2004-12-31 2008-01-03 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Method for diagnosing an/or predicting preeclampsia and/or related disorders
FI20050011A (en) * 2005-01-05 2006-07-06 Jurilab Ltd Oy The method and test kit for the risk of type 2 diabetes mellitus in the detection of
WO2006074914A3 (en) * 2005-01-13 2006-08-31 Iedrich Miescher Inst For Biom Human rna helicase and therapeutic uses thereof
US7521195B1 (en) 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
JP2009516693A (en) 2005-11-21 2009-04-23 イエール ユニバーシティ Method of modulating Renaraze (monoamine oxidase c)
WO2007060899A1 (en) * 2005-11-22 2007-05-31 National University Corporation Nagoya University Application of actin-binding protein to disease associated with cell motility
EP1986489A2 (en) 2006-02-24 2008-11-05 Schering Corporation Npc1l1 orthologues
EP2061814B1 (en) 2006-10-27 2012-06-06 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
US7960345B2 (en) * 2007-05-02 2011-06-14 Snu R&Db Foundation Angiogenesis inhibitor comprising meteorin as an active ingredient
EP2173379B1 (en) 2007-07-02 2015-09-02 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
WO2009003694A3 (en) * 2007-07-03 2009-03-05 Andreas Reichert Method for treating diseases related to mitochondrial dysfunction
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
JP2011509076A (en) 2007-12-28 2011-03-24 ノボ・ノルデイスク・エー/エス ddr1 mediated cell purification of said cells via a precursor of pancreatic endocrine cells
JP5616888B2 (en) 2008-07-24 2014-10-29 エヌエスジーン・アクティーゼルスカブNsGene A/S The therapeutic use of growth factor metrnl
US8404242B2 (en) 2009-03-16 2013-03-26 Atyr Pharma, Inc. Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
US8148498B2 (en) 2009-04-10 2012-04-03 Eli Lilly And Company DKK-1 antibodies
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
WO2011066503A3 (en) 2009-11-30 2011-10-27 Genentech, Inc. Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
JP5819314B2 (en) 2009-12-11 2015-11-24 エータイアー ファーマ, インコーポレイテッド Aminoacyl-tRNA synthetase for modulating inflammation
CA2804424A1 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
EP2621512B1 (en) 2010-10-01 2016-04-06 NsGene A/S Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
WO2013012747A1 (en) 2011-07-15 2013-01-24 Oncomed Pharmaceuticals, Inc. Rspo binding agents and uses thereof
CA2846511A1 (en) 2011-09-05 2013-03-14 Nsgene A/S Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain
EP3311847A1 (en) 2012-02-16 2018-04-25 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
CN104854132A (en) 2012-07-13 2015-08-19 昂考梅德药品有限公司 RSPO3 binding agents and uses thereof
CA2907046A1 (en) 2013-03-15 2014-09-18 Atyr Pharma, Inc. Histidyl-trna synthetase-fc conjugates
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
WO2016044295A1 (en) 2014-09-16 2016-03-24 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049306A1 (en) * 1997-04-29 1998-11-05 Incyte Pharmaceuticals, Inc. Human c-type lectin
WO1998054209A2 (en) * 1997-05-31 1998-12-03 Peptide Therapeutics Limited Human mast cell function-associated antigen (mafa) and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998049306A1 (en) * 1997-04-29 1998-11-05 Incyte Pharmaceuticals, Inc. Human c-type lectin
WO1998054209A2 (en) * 1997-05-31 1998-12-03 Peptide Therapeutics Limited Human mast cell function-associated antigen (mafa) and uses thereof

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
DATABASE EBI 1 November 1996 (1996-11-01), XP002329122, retrieved from EBI Database accession no. Q04490 *
DATABASE EMBL [online] 15 November 1992 (1992-11-15), "Homo Sapiens P5-1 mRNA, complete cds.", XP002329509, retrieved from EBI Database accession no. HSMHP *
DATABASE EMBL [online] 19 January 1998 (1998-01-19), "nx26e06.s1 NCI_CGAP_GC4 Homo sapiens cDNA clone IMAGE:1257250 3', mRNA sequence.", XP002346073, retrieved from EBI Database accession no. AA742567 *
DATABASE EMBL [online] 25 January 1999 (1999-01-25), "CITBI-E1-2541D22.TR CITBI-E1 Homo sapiens genomic clone 2541D22, genomic survey sequence.", XP002346074, retrieved from EBI Database accession no. AQ356422 *
DATABASE EMBL [online] 27 August 1998 (1998-08-27), "Homo sapiens PAC clone RP4-701O16 from 7, complete sequence.", XP002346072, retrieved from EBI Database accession no. AC005531 *
DATABASE EMBL [online] 4 December 1998 (1998-12-04), "Homo sapiens DNA, P5-1-hom region.", XP002329406, retrieved from EBI Database accession no. D88650 *
DATABASE EMBL 21 April 1994 (1994-04-21), "H.sapiens P5-1g DNA", XP002329407, retrieved from EBI Database accession no. Z31714 *
DATABASE EMBL 30 June 1999 (1999-06-30), "wi73f11.x1 NCI_CGAP_Kid12 Homo sapiens cDNA clone IMAGE:2398989 3' similar to TR:Q04490 Q04490 P5-1 PROTEIN.", XP002329408, retrieved from EBI Database accession no. AI765329 *
DATABASE UniProt 1 June 1998 (1998-06-01), "Mast cell function-associated antigen", XP002346076, retrieved from EBI Database accession no. O43198 *
DATABASE UniProt 1 November 1998 (1998-11-01), "ITIM-containing receptor MAFA_l (Mast cell function-associated antigen homolog)", XP002346075, retrieved from EBI Database accession no. 075613 *
See also references of WO0157190A3 *
SHIINA TAKASHI ET AL.: "Physical mapping between the S and HLA-E genes in the human MHC class I region: Construction of a BAC, PAC, and cosmid contig", IMMUNOGENETICS, vol. 48, no. 6, November 1998 (1998-11-01), pages 402 - 407, XP002329404, ISSN: 0093-7711 *
VERNET C. ET AL.: "A novel coding sequence belonging to a new multicopy gene family mapping within the human MHC class I region", IMMUNOGENETICS, vol. 38, no. 1, 1993, pages 47 - 53, XP002904811, ISSN: 0093-7711 *

Also Published As

Publication number Publication date Type
CA2399776A1 (en) 2001-08-09 application
EP1572987A2 (en) 2005-09-14 application
WO2001057190A2 (en) 2001-08-09 application
WO2001057190A3 (en) 2006-11-16 application

Similar Documents

Publication Publication Date Title
WO2002094870A8 (en) Proteins and nucleic acids encoding same
WO2003003984A9 (en) Novel proteins and nucleic acids encoding same
GB9924871D0 (en) Assay
GB9922527D0 (en) Assay
GB9927351D0 (en) Assay
GB9929272D0 (en) Assay
GB9926384D0 (en) Assay
GB9917659D0 (en) Assay
GB9910100D0 (en) Assay
GB9905008D0 (en) Assay
GB9929308D0 (en) Assay
GB9919134D0 (en) Assay
GB9923208D0 (en) Assay
GB9905007D0 (en) Assay
GB9923599D0 (en) Assay
GB9703827D0 (en) Novel protein
GB9706119D0 (en) Novel protein
GB9718403D0 (en) Easy-lay brick
GB0112342D0 (en) Polypeptides
GB0105063D0 (en) Polypeptides
GB0005798D0 (en) Ceramic pigments
GB0008899D0 (en) DNA analysis
GB9812793D0 (en) Nucleotide sequences and protein sequences
GB9907216D0 (en) Peptide
GB2359641B (en) Mapping circuitry and method

Legal Events

Date Code Title Description
AK Designated contracting states:

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17P Request for examination filed

Effective date: 20020826

A4 Despatch of supplementary search report

Effective date: 20051012

RIC1 Classification (correction)

Ipc: C07H 21/04 20060101AFI20070319BHEP

17Q First examination report

Effective date: 20080328

18W Withdrawn

Effective date: 20080515